Il y a eu 50 transactions d'initiés récentes enregistrées pour Cellectar Biosciences, Inc. (CLRB), dont 46 achats et 3 ventes. Le total des achats d'initiés s'élève à $8.96M et le total des ventes d'initiés à $731.99.
Les initiés notables ayant une activité récente comprennent Neis John, Caruso James V, Longcor Jarrod. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — CLRB
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2025-12-12 |
Neis John |
Director |
Vente Informative |
198 |
$3.70 |
$731.99 |
10 |
| 2025-07-02 |
Caruso James V |
Chief Executive Officer |
Achat Informatif |
10,000 |
$5.25 |
$52.5K |
10,000 |
| 2025-07-02 |
Longcor Jarrod |
Chief Operating Officer |
Achat Informatif |
10,000 |
$5.25 |
$52.5K |
10,000 |
| 2025-07-02 |
Kolean Chad J |
Chief Financial Officer |
Achat Informatif |
5,000 |
$5.25 |
$26.25K |
5,000 |
| 2025-02-14 |
Driscoll Frederick W |
Director |
Attribution de RSU |
60,000 |
$0.29 |
$17.4K |
60,000 |
| 2025-02-14 |
Neis John |
Director |
Attribution de RSU |
60,000 |
$0.29 |
$17.4K |
60,000 |
| 2025-02-14 |
Caruso James V |
President and CEO |
Attribution de RSU |
900,000 |
$0.29 |
$261K |
900,000 |
| 2025-02-14 |
Swirsky Douglas J |
Director |
Attribution de RSU |
90,000 |
$0.29 |
$26.1K |
90,000 |
| 2025-02-14 |
Loren Stefan |
Director |
Attribution de RSU |
60,000 |
$0.29 |
$17.4K |
60,000 |
| 2025-02-14 |
Longcor Jarrod |
Chief Operating Officer |
Attribution de RSU |
500,000 |
$0.29 |
$145K |
500,000 |
| 2025-02-14 |
Kolean Chad J |
Chief Financial Officer |
Attribution de RSU |
290,000 |
$0.29 |
$84.1K |
290,000 |
| 2025-02-14 |
Chanan-khan Asher |
Director |
Attribution de RSU |
60,000 |
$0.29 |
$17.4K |
60,000 |
| 2025-01-10 |
Longcor Jarrod |
Chief Operating Officer |
Achat Informatif |
30,000 |
$0.28 |
$8.4K |
83,141 |
| 2024-06-14 |
Driscoll Frederick W |
Director |
Attribution de RSU |
60,000 |
$2.58 |
$154.8K |
60,000 |
| 2024-06-14 |
Neis John |
Director |
Attribution de RSU |
60,000 |
$2.58 |
$154.8K |
60,000 |
| 2024-06-14 |
Caruso James V |
President and CEO |
Attribution de RSU |
900,000 |
$2.65 |
$2.39M |
900,000 |
| 2024-06-14 |
Swirsky Douglas J |
Director |
Attribution de RSU |
90,000 |
$2.58 |
$232.2K |
90,000 |
| 2024-06-14 |
Loren Stefan |
Director |
Attribution de RSU |
60,000 |
$2.58 |
$154.8K |
60,000 |
| 2024-06-14 |
Longcor Jarrod |
Chief Operating Officer |
Attribution de RSU |
500,000 |
$2.65 |
$1.33M |
500,000 |
| 2024-06-14 |
Kolean Chad J |
Chief Financial Officer |
Attribution de RSU |
290,000 |
$2.65 |
$768.5K |
290,000 |
| 2024-06-14 |
Chanan-khan Asher |
Director |
Attribution de RSU |
60,000 |
$2.58 |
$154.8K |
60,000 |
| 2024-06-14 |
Lea Darrell Shane |
Chief Commercial Officer |
Attribution de RSU |
260,000 |
$2.65 |
$689K |
260,000 |
| 2024-06-14 |
Shustov Andrei |
Senior Vice President, Medical |
Attribution de RSU |
260,000 |
$2.65 |
$689K |
260,000 |
| 2023-12-08 |
Caruso James V |
President and CEO |
Attribution de RSU |
40,596 |
- |
- |
49,236 |
| 2023-12-08 |
Longcor Jarrod |
Chief Operating Officer |
Attribution de RSU |
42,927 |
- |
- |
53,141 |
| 2023-12-08 |
Kolean Chad J |
Chief Financial Officer |
Attribution de RSU |
42,554 |
- |
- |
42,578 |
| 2023-12-08 |
Lea Darrell Shane |
Chief Commercial Officer |
Attribution de RSU |
39,599 |
- |
- |
39,599 |
| 2023-12-08 |
Shustov Andrei |
Senior Vice President, Medical |
Attribution de RSU |
47,856 |
- |
- |
55,038 |
| 2023-06-28 |
Driscoll Frederick W |
Director |
Attribution de RSU |
25,000 |
$1.85 |
$46.25K |
47,650 |
| 2023-06-28 |
Neis John |
Director |
Attribution de RSU |
25,000 |
$1.85 |
$46.25K |
47,887 |
| 2023-06-28 |
Swirsky Douglas J |
Director |
Attribution de RSU |
37,500 |
$1.85 |
$69.38K |
71,925 |
| 2023-06-28 |
Loren Stefan |
Director |
Attribution de RSU |
25,000 |
$1.85 |
$46.25K |
47,885 |
| 2023-06-28 |
Chanan-khan Asher |
Director |
Attribution de RSU |
25,000 |
$1.85 |
$46.25K |
40,600 |
| 2023-06-23 |
Caruso James V |
President and CEO |
Attribution de RSU |
261,000 |
$1.68 |
$438.48K |
261,000 |
| 2023-06-23 |
Longcor Jarrod |
Chief Operating Officer |
Attribution de RSU |
144,000 |
$1.68 |
$241.92K |
144,000 |
| 2023-06-23 |
Kolean Chad J |
Chief Financial Officer |
Attribution de RSU |
104,000 |
$1.68 |
$174.72K |
104,000 |
| 2023-06-23 |
Lea Darrell Shane |
Chief Commercial Officer |
Attribution de RSU |
100,000 |
$1.68 |
$168K |
100,000 |
| 2023-02-15 |
Shustov Andrei |
Senior Vice President, Medical |
Cession |
- |
- |
- |
7,182 |
| 2023-02-15 |
Shustov Andrei |
Senior Vice President, Medical |
Attribution de RSU |
100,000 |
$1.67 |
$167K |
100,000 |
| 2023-01-17 |
Caruso James V |
President and CEO |
Attribution de RSU |
261,000 |
- |
- |
261,000 |
| 2023-01-17 |
Longcor Jarrod |
Chief Operating Officer |
Attribution de RSU |
144,000 |
- |
- |
144,000 |
| 2023-01-17 |
Kolean Chad J |
Chief Financial Officer |
Attribution de RSU |
104,000 |
- |
- |
104,000 |
| 2022-11-21 |
Lea Darrell Shane |
Officer |
Inconnu |
- |
- |
- |
- |
| 2022-11-21 |
Lea Darrell Shane |
Chief Commercial Officer |
Attribution de RSU |
100,000 |
- |
- |
100,000 |
| 2022-06-24 |
Driscoll Frederick W |
Director |
Attribution de RSU |
7,800 |
- |
- |
7,800 |
| 2022-06-24 |
Neis John |
Director |
Attribution de RSU |
7,800 |
- |
- |
7,800 |
| 2022-06-24 |
Swirsky Douglas J |
Director |
Attribution de RSU |
11,700 |
$4.10 |
$47.97K |
11,700 |
| 2022-06-24 |
Loren Stefan |
Director |
Attribution de RSU |
7,800 |
$4.10 |
$31.98K |
7,800 |
| 2022-06-24 |
Chanan-khan Asher |
Director |
Attribution de RSU |
7,800 |
- |
- |
7,800 |
| 2022-02-24 |
Kolean Chad J |
Chief Financial Officer |
Cession |
- |
- |
- |
240 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
